{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T15:47:55Z","timestamp":1790696875340,"version":"4.1.0"},"reference-count":118,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2019,2,22]],"date-time":"2019-02-22T00:00:00Z","timestamp":1550793600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,9,25]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Effective diphtheria, tetanus toxoids, whole-cell pertussis (DTwP) vaccines became available in the 1930s, and they were put into routine use in the United States in the 1940s. Their use reduced the average rate of reported pertussis cases from 157 in 100 000 in the prevaccine era to &lt;1 in 100 000 in the 1970s. Because of alleged reactions (encephalopathy and death), several countries discontinued (Sweden) or markedly decreased (United Kingdom, Germany, Japan) use of the vaccine. During the 20th century, Bordetella pertussis was studied extensively in animal model systems, and many \u201ctoxins\u201d and protective antigens were described. A leader in B pertussis research was Margaret Pittman of the National Institutes of Health\/US Food and Drug Administration. She published 2 articles suggesting that pertussis was a pertussis toxin (PT)-mediated disease. Dr Pittman\u2019s views led to the idea that less-reactogenic acellular vaccines could be produced. The first diphtheria, tetanus, pertussis (DTaP) vaccines were developed in Japan and put into routine use there. Afterward, DTaP vaccines were developed in the Western world, and definitive efficacy trials were carried out in the 1990s. These vaccines were all less reactogenic than DTwP vaccines, and despite the fact that their efficacy was less than that of DTwP vaccines, they were approved in the United States and many other countries. DTaP vaccines replaced DTwP vaccines in the United States in 1997. In the last 13 years, major pertussis epidemics have occurred in the United States, and numerous studies have shown the deficiencies of DTaP vaccines, including the small number of antigens that the vaccines contain and the type of cellular immune response that they elicit. The type of cellular response a predominantly, T2 response results in less efficacy and shorter duration of protection. Because of the small number of antigens (3\u20135 in DTaP vaccines vs &gt;3000 in DTwP vaccines), linked-epitope suppression occurs. Because of linked-epitope suppression, all children who were primed by DTaP vaccines will be more susceptible to pertussis throughout their lifetimes, and there is no easy way to decrease this increased lifetime susceptibility.<\/jats:p>","DOI":"10.1093\/jpids\/piz005","type":"journal-article","created":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T17:30:18Z","timestamp":1548264618000},"page":"334-341","source":"Crossref","is-referenced-by-count":66,"title":["The 112-Year Odyssey of Pertussis and Pertussis Vaccines\u2014Mistakes Made and Implications for the Future"],"prefix":"10.1093","volume":"8","author":[{"given":"James D","family":"Cherry","sequence":"first","affiliation":[{"name":"Department of Pediatrics, David Geffen School of Medicine at UCLA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,2,22]]},"reference":[{"key":"2019100522583970400_CIT0001","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1128\/CMR.18.2.326-382.2005","article-title":"Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies","volume":"18","author":"Mattoo","year":"2005","journal-title":"Clin Microbiol Rev"},{"key":"2019100522583970400_CIT0002","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s40471-015-0041-9","article-title":"The history of pertussis (whooping cough): 1906\u20132015: facts, myths, and misconceptions","volume":"2","author":"Cherry","year":"2015","journal-title":"Curr Epidemiol Rep"},{"key":"2019100522583970400_CIT0003","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1093\/clinids\/1.3.401","article-title":"Pertussis toxin: the cause of the harmful effects and prolonged immunity of whooping cough. A hypothesis","volume":"1","author":"Pittman","year":"1979","journal-title":"Rev Infect Dis"},{"key":"2019100522583970400_CIT0004","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/00006454-198409000-00019","article-title":"The concept of pertussis as a toxin-mediated disease","volume":"3","author":"Pittman","year":"1984","journal-title":"Pediatr Infect Dis"},{"key":"2019100522583970400_CIT0005","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S0140-6736(84)90061-8","article-title":"Development of a pertussis component vaccine in Japan","volume":"1","author":"Sato","year":"1984","journal-title":"Lancet"},{"key":"2019100522583970400_CIT0006","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1542\/peds.96.3.548","article-title":"Comparison of 13 acellular pertussis vaccines: overview and serologic response","volume":"96","author":"Edwards","year":"1995","journal-title":"Pediatrics"},{"key":"2019100522583970400_CIT0007","first-page":"1159","article-title":"Pertussis and other Bordetella infections","volume-title":"Feigin and Cherry\u2019s Textbook of Pediatric Infectious Diseases","author":"Cherry","year":"2019","edition":"8th ed"},{"key":"2019100522583970400_CIT0008","article-title":"Edwards Km, Decker MD, Montimer EA. Pertussis Vaccines. In: Plotkin SA, Orenstein WA eds. Vaccines. 3rd ed Philadelphia, PA: Sannders; 1999. p 293-344."},{"key":"2019100522583970400_CIT0009","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(88)91778-3","article-title":"Placebo-controlled trial of two acellular pertussis vaccines in Sweden: protective efficacy and adverse events","volume":"1","author":"Ad Hoc Group for the Study of Pertussis Vaccines","year":"1988","journal-title":"Lancet"},{"key":"2019100522583970400_CIT0010","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1056\/NEJM199602083340602","article-title":"A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine","volume":"334","author":"Gustafsson","year":"1996","journal-title":"N Engl J Med"},{"key":"2019100522583970400_CIT0011","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1542\/peds.2005-2746","article-title":"Long-term follow-up of Swedish children vaccinated with acellular pertussis vaccines at 3, 5, and 12 months of age indicates the need for a booster dose at 5 to 7 years of age","volume":"118","author":"Gustafsson","year":"2006","journal-title":"Pediatrics"},{"key":"2019100522583970400_CIT0012","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1542\/peds.102.3.546","article-title":"Comparative efficacy of the Lederle\/Takeda acellular pertussis component DTP (DTaP) vaccine and Lederle whole-cell component DTP vaccine in German children after household exposure. Pertussis Vaccine Study Group","volume":"102","author":"Heininger","year":"1998","journal-title":"Pediatrics"},{"key":"2019100522583970400_CIT0013","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1097\/00006454-199711000-00007","article-title":"Efficacy of a two-component acellular pertussis vaccine in infants","volume":"16","author":"Liese","year":"1997","journal-title":"Pediatr Infect Dis J"},{"key":"2019100522583970400_CIT0014","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0140-6736(97)06508-2","article-title":"Randomised controlled trial of two-component, three-component, and five-component acellular pertussis vaccines compared with whole-cell pertussis vaccine. Ad Hoc Group for the Study of Pertussis Vaccines","volume":"350","author":"Olin","year":"1997","journal-title":"Lancet"},{"key":"2019100522583970400_CIT0015","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/S0264-410X(98)00040-1","article-title":"Persistence of protection through 33 months of age provided by immunization in infancy with two three-component acellular pertussis vaccines. Stage II Working Group","volume":"16","author":"Salmaso","year":"1998","journal-title":"Vaccine"},{"key":"2019100522583970400_CIT0016","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1016\/S0264-410X(97)00100-X","article-title":"A randomized double-blind trial comparing a two-component acellular to a whole-cell pertussis vaccine in Senegal","volume":"15","author":"Simondon","year":"1997","journal-title":"Vaccine"},{"key":"2019100522583970400_CIT0017","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1542\/peds.101.1.1","article-title":"A comparative efficacy trial in Germany in infants who received either the Lederle\/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP vaccine, or DT vaccine","volume":"101","author":"Stehr","year":"1998","journal-title":"Pediatrics"},{"key":"2019100522583970400_CIT0018","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/00006454-199702000-00003","article-title":"Unchanged efficacy of a pertussis toxoid vaccine throughout the two years after the third vaccination of infants","volume":"16","author":"Taranger","year":"1997","journal-title":"Pediatr Infect Dis J"},{"key":"2019100522583970400_CIT0019","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJM199510193331604","article-title":"A placebo-controlled trial of a pertussis-toxoid vaccine","volume":"333","author":"Trollfors","year":"1995","journal-title":"N Engl J Med"},{"key":"2019100522583970400_CIT0020","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1001\/jama.1996.03530250041024","article-title":"Efficacy of acellular pertussis vaccine in early childhood after household exposure","volume":"275","author":"Schmitt","year":"1996","journal-title":"JAMA"},{"key":"2019100522583970400_CIT0021","first-page":"139","article-title":"Historical perspective on pertussis and use of vaccines to prevent it","volume":"2","author":"Cherry","year":"2007","journal-title":"Microbe"},{"key":"2019100522583970400_CIT0022","first-page":"395","volume-title":"Bacillary and Rickettsial Infections, Acute and Chronic, a Textbook: Black Death to White Plague","author":"Holmes","year":"1940"},{"key":"2019100522583970400_CIT0023","first-page":"115","article-title":"Pertussis: the histological lesion in the respiratory tract","volume":"27","author":"Mallory","year":"1912","journal-title":"J Med Res"},{"key":"2019100522583970400_CIT0024","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1542\/peds.2004-2648","article-title":"The epidemiology of pertussis: a comparison of the epidemiology of the disease pertussis with the epidemiology of Bordetella pertussis infection","volume":"115","author":"Cherry","year":"2005","journal-title":"Pediatrics"},{"key":"2019100522583970400_CIT0025","first-page":"1","article-title":"The epidemiology of pertussis and pertussis immunization in the United Kingdom and the United States: a comparative study","volume":"14","author":"Cherry","year":"1984","journal-title":"Curr Probl Pediatr"},{"key":"2019100522583970400_CIT0026","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1542\/peds.81.6.933","article-title":"Report of the Task Force on Pertussis and Pertussis Immunization\u20141988","volume":"81","author":"Cherry","year":"1988","journal-title":"Pediatrics"},{"key":"2019100522583970400_CIT0027","first-page":"451","article-title":"Epidemiological considerations for whooping cough eradication","volume-title":"Pathogenesis and Immunity in Pertussis","author":"Fine","year":"1988"},{"key":"2019100522583970400_CIT0028","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/S0140-6736(82)92214-0","article-title":"The recurrence of whooping cough: possible implications for assessment of vaccine efficacy","volume":"1","author":"Fine","year":"1982","journal-title":"Lancet"},{"key":"2019100522583970400_CIT0029","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1093\/clinids\/9.5.866","article-title":"Reflections on the efficacy of pertussis vaccines","volume":"9","author":"Fine","year":"1987","journal-title":"Rev Infect Dis"},{"key":"2019100522583970400_CIT0030","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1097\/01.inf.0000145263.37198.2b","article-title":"Infant pertussis: who was the source?","volume":"23","author":"Bisgard","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"2019100522583970400_CIT0031","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/01.inf.0000256750.07118.ee","article-title":"Prospective multinational study of pertussis infection in hospitalized infants and their household contacts","volume":"26","author":"Kowalzik","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"2019100522583970400_CIT0032","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/01.inf.0000258699.64164.6d","article-title":"Transmission of Bordetella pertussis to young infants","volume":"26","author":"Wendelboe","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"2019100522583970400_CIT0033","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1086\/652281","article-title":"Pertussis disease burden in household: how to protect young infants","volume":"50","author":"deGreeff","year":"2010","journal-title":"Clin Infect Dis"},{"key":"2019100522583970400_CIT0034","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1542\/peds.2015-1120","article-title":"Sources of infant pertussis infection in the United States","volume":"136","author":"Skoff","year":"2015","journal-title":"Pediatrics"},{"key":"2019100522583970400_CIT0035","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1086\/655826","article-title":"The present and future control of pertussis","volume":"51","author":"Cherry","year":"2010","journal-title":"Clin Infect Dis"},{"key":"2019100522583970400_CIT0036","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/cid\/ciw550","article-title":"Pertussis in young infants throughout the world","volume":"63","author":"Cherry","year":"2016","journal-title":"Clin Infect Dis"},{"key":"2019100522583970400_CIT0037","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1586\/14760584.2014.935765","article-title":"Adult pertussis in the pre- and post-vaccine eras: lifelong vaccine-induced immunity?","volume":"13","author":"Cherry","year":"2014","journal-title":"Expert Rev Vaccines"},{"key":"2019100522583970400_CIT0038","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1086\/515058","article-title":"Epidemiological, clinical, and laboratory aspects of pertussis in adults","volume":"28","author":"Cherry","year":"1999","journal-title":"Clin Infect Dis"},{"key":"2019100522583970400_CIT0039","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1086\/515057","article-title":"Pertussis in the preantibiotic and prevaccine era, with emphasis on adult pertussis","volume":"28","author":"Cherry","year":"1999","journal-title":"Clin Infect Dis"},{"key":"2019100522583970400_CIT0040","doi-asserted-by":"crossref","first-page":"e1003418","DOI":"10.1371\/journal.ppat.1003418","article-title":"Pertussis: challenges today and for the future","volume":"9","author":"Cherry","year":"2013","journal-title":"PLoS Pathog"},{"key":"2019100522583970400_CIT0041","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1086\/313707","article-title":"Prolonged afebrile nonproductive cough illnesses in American soldiers in Korea: a serological search for causation","volume":"30","author":"Vincent","year":"2000","journal-title":"Clin Infect Dis"},{"key":"2019100522583970400_CIT0042","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1093\/clinids\/21.3.639","article-title":"Frequency of unrecognized Bordetella pertussis infections in adults","volume":"21","author":"Deville","year":"1995","journal-title":"Clin Infect Dis"},{"key":"2019100522583970400_CIT0043","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1086\/313913","article-title":"Antibody responses to Bordetella pertussis antigens and clinical correlations in elderly community residents","volume":"31","author":"Hodder","year":"2000","journal-title":"Clin Infect Dis"},{"key":"2019100522583970400_CIT0044","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jinf.2005.10.020","article-title":"The incidence of Bordetella pertussis infections estimated in the population from a combination of serological surveys","volume":"53","author":"de Melker","year":"2006","journal-title":"J Infect"},{"key":"2019100522583970400_CIT0045","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1086\/319853","article-title":"Population-based incidence of pertussis among adolescents and adults, Minnesota, 1995\u20131996","volume":"183","author":"Strebel","year":"2001","journal-title":"J Infect Dis"},{"key":"2019100522583970400_CIT0046","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1056\/NEJMoa050824","article-title":"Efficacy of an acellular pertussis vaccine among adolescents and adults","volume":"353","author":"Ward","year":"2005","journal-title":"N Engl J Med"},{"key":"2019100522583970400_CIT0047","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1542\/peds.102.4.909","article-title":"The effect of investigator compliance (observer bias) on calculated efficacy in a pertussis vaccine trial","volume":"102","author":"Cherry","year":"1998","journal-title":"Pediatrics"},{"key":"2019100522583970400_CIT0048","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1097\/01.inf.0000160914.59160.41","article-title":"Duration of immunity against pertussis after natural infection or vaccination","volume":"24","author":"Wendelboe","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"2019100522583970400_CIT0049","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1093\/clinids\/21.4.860","article-title":"Pertussis in German adults","volume":"21","author":"Schmitt-Groh\u00e9","year":"1995","journal-title":"Clin Infect Dis"},{"key":"2019100522583970400_CIT0050","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1093\/clinids\/14.2.464","article-title":"A search for Bordetella pertussis infection in university students","volume":"14","author":"Mink","year":"1992","journal-title":"Clin Infect Dis"},{"key":"2019100522583970400_CIT0051","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1093\/clinids\/20.5.1271","article-title":"Comparison of values of antibody to Bordetella pertussis antigens in young German and American men","volume":"20","author":"Cherry","year":"1995","journal-title":"Clin Infect Dis"},{"key":"2019100522583970400_CIT0052","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/S0022-3476(34)80039-X","article-title":"Pertussis in adults","volume":"5","author":"Mannerstedt","year":"1934","journal-title":"J Pediatr"},{"key":"2019100522583970400_CIT0053","volume-title":"Whooping Cough","author":"Lapin","year":"1943"},{"key":"2019100522583970400_CIT0054","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1001\/jama.1939.02800040023007","article-title":"Whooping cough: new phases of the work on immunization and prophylaxis","volume":"112","author":"Sauer","year":"1939","journal-title":"JAMA"},{"key":"2019100522583970400_CIT0055","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1056\/NEJM192501081920202","article-title":"Whooping cough: its bacteriology, diagnosis, prevention and treatment","volume":"192","author":"Madsen","year":"1925","journal-title":"Boston Med Surg J"},{"key":"2019100522583970400_CIT0056","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1001\/jama.1914.02570120027007","article-title":"Use of a series of vaccines in the prophylaxis and treatment of an epidemic of pertussis","volume":"63","author":"Hess","year":"1914","journal-title":"JAMA"},{"key":"2019100522583970400_CIT0057","first-page":"128","article-title":"Whooping cough","volume-title":"Pediatrics","author":"Friedlander","year":"1925"},{"key":"2019100522583970400_CIT0058","first-page":"290","article-title":"The epidemiology of pertussis","volume-title":"Am J Dis Child","author":"Luttinger","year":"1916"},{"key":"2019100522583970400_CIT0059","first-page":"48","article-title":"Le microbe de la coqueluche","volume":"20","author":"Bordet","year":"1906","journal-title":"Ann Inst Pasteur (Paris)"},{"key":"2019100522583970400_CIT0060","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1542\/peds.1.4.437","article-title":"Encephalopathies following prophylactic pertussis vaccine","volume":"1","author":"Byers","year":"1948","journal-title":"Pediatrics"},{"key":"2019100522583970400_CIT0061","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1136\/bmj.2.5087.24","article-title":"Neurological complications of pertussis immunization","volume":"2","author":"Berg","year":"1958","journal-title":"Br Med J"},{"key":"2019100522583970400_CIT0062","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1136\/adc.49.1.46","article-title":"Neurological complications of pertussis inoculation","volume":"49","author":"Kulenkampff","year":"1974","journal-title":"Arch Dis Child"},{"key":"2019100522583970400_CIT0063","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1136\/bmj.4.5575.320","article-title":"Further experience of reactions, especially of a cerebral nature, in conjunction with triple vaccination: a study based on vaccinations in Sweden 1959-65","volume":"4","author":"Str\u00f6m","year":"1967","journal-title":"Br Med J"},{"key":"2019100522583970400_CIT0064","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S0140-6736(77)91028-5","article-title":"Vaccination against whooping-cough. Efficacy versus risks","volume":"1","author":"Stewart","year":"1977","journal-title":"Lancet"},{"key":"2019100522583970400_CIT0065","first-page":"528","article-title":"DTP vaccine litigation","volume":"140","author":"Hinman","year":"1986","journal-title":"Am J Dis Child"},{"key":"2019100522583970400_CIT0066","first-page":"7","volume-title":"Whooping Cough: Reports From the Committee on Safety of Medicines and the Joint Committee on Vaccination and Immunization","author":"Alderslade","year":"1981"},{"key":"2019100522583970400_CIT0067","first-page":"389","article-title":"Pertussis vaccine and whooping cough as risk factors in acute neurological illness and death in young children","volume":"61","author":"Miller","year":"1985","journal-title":"Dev Biol Stand"},{"key":"2019100522583970400_CIT0068","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1136\/bmj.307.6913.1171","article-title":"Pertussis immunisation and serious acute neurological illnesses in children","volume":"307","author":"Miller","year":"1993","journal-title":"BMJ"},{"key":"2019100522583970400_CIT0069","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1001\/jama.1990.03440120063038","article-title":"Risk of seizures and encephalopathy after immunization with the diphtheria-tetanus-pertussis vaccine","volume":"263","author":"Griffin","year":"1990","journal-title":"JAMA"},{"key":"2019100522583970400_CIT0070","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1001\/jama.1994.03510250053034","article-title":"Risk of serious acute neurological illness after immunization with diphtheria-tetanus-pertussis vaccine. A population-based case-control study","volume":"271","author":"Gale","year":"1994","journal-title":"JAMA"},{"key":"2019100522583970400_CIT0071","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/S0140-6736(83)92655-7","article-title":"Infantile spasms and pertussis immunisation","volume":"1","author":"Bellman","year":"1983","journal-title":"Lancet"},{"key":"2019100522583970400_CIT0072","first-page":"345","volume":"81","author":"Walker","year":"1988","journal-title":"Neurological Events Following Diphtheria-Tetanus Pertussis Immunization. Pediatrics"},{"key":"2019100522583970400_CIT0073","first-page":"801","article-title":"Relationship of pertussis immunization to the onset of neurologic disorders: a retrospective epidemiologic study","volume":"1988; 113","author":"Shields","journal-title":"J Pediatr"},{"key":"2019100522583970400_CIT0074","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1001\/jama.1990.03440120101046","article-title":"\u201cPertussis vaccine encephalopathy\u201d: it is time to recognize it as the myth that it is","volume":"263","author":"Cherry","year":"1990","journal-title":"JAMA"},{"key":"2019100522583970400_CIT0075","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1097\/01.inf.0000130075.56368.02","article-title":"Lack of evidence of encephalopathy related to pertussis vaccine: active surveillance by IMPACT, Canada, and 1993\u20132002","volume":"23","author":"Moore","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"2019100522583970400_CIT0076","first-page":"47","article-title":"Pertussis and the vaccine controversy","volume-title":"Immunization","author":"Cherry","year":"1989"},{"key":"2019100522583970400_CIT0077","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1001\/archpedi.1984.02140480006002","article-title":"Recurrent seizures after diphtheria, tetanus, and pertussis immunization. Cause and effect v temporal association","volume":"138","author":"Cherry","year":"1984","journal-title":"Am J Dis Child"},{"key":"2019100522583970400_CIT0078","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1542\/peds.79.4.598","article-title":"Diphtheria-tetanus-pertussis immunization and sudden infant death: results of the National Institute of Child Health and Human Development Cooperative Epidemiological Study of Sudden Infant Death Syndrome risk factors","volume":"79","author":"Hoffman","year":"1987","journal-title":"Pediatrics"},{"key":"2019100522583970400_CIT0079","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1056\/NEJM198809083191006","article-title":"Risk of sudden infant death syndrome after immunization with the diphtheria-tetanus-pertussis vaccine","volume":"319","author":"Griffin","year":"1988","journal-title":"N Engl J Med"},{"key":"2019100522583970400_CIT0080","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1086\/589753","article-title":"Pathology and pathogenesis of fatal Bordetella pertussis infection in infants","volume":"47","author":"Paddock","year":"2008","journal-title":"Clin Infect Dis"},{"key":"2019100522583970400_CIT0081","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1586\/14760584.2014.935766","article-title":"Pathogenesis and histopathology of pertussis: implications for immunization","volume":"13","author":"Cherry","year":"2014","journal-title":"Expert Rev Vaccines"},{"key":"2019100522583970400_CIT0082","doi-asserted-by":"crossref","first-page":"e123","DOI":"10.1093\/jpids\/pix044","article-title":"Treatment of pertussis","volume":"17","author":"Cherry","year":"2018","journal-title":"J Pediatric Infect Dis Soc"},{"key":"2019100522583970400_CIT0083","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1093\/cid\/civ472","article-title":"Risk factors associated with infant deaths from pertussis: a case-control study","volume":"61","author":"Winter","year":"2015","journal-title":"Clin Infect Dis"},{"key":"2019100522583970400_CIT0084","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1097\/INF.0b013e31828c3bb3","article-title":"Exchange blood transfusion in the management of severe pertussis in young infants","volume":"32","author":"Nieves","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"2019100522583970400_CIT0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jpids\/pis105","article-title":"Characteristics of severe Bordetella pertussis infection among infants \u226490 days of age admitted to pediatric intensive care units\u2014Southern California, September 2009\u2013June 2011","volume":"2","author":"Murray","year":"2013","journal-title":"J Pediatric Infect Dis Soc"},{"key":"2019100522583970400_CIT0086","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/INF.0000000000001710","article-title":"An observational study of severe pertussis in 100 infants \u2264120 days of age","volume":"37","author":"Cherry","year":"2018","journal-title":"Pediatr Infect Dis J"},{"key":"2019100522583970400_CIT0087","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1073\/pnas.1314688110","article-title":"Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model","volume":"111","author":"Warfel","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2019100522583970400_CIT0088","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1586\/14760584.2014.946016","article-title":"The baboon model of pertussis: effective use and lessons for pertussis vaccines","volume":"13","author":"Warfel","year":"2014","journal-title":"Expert Rev Vaccines"},{"key":"2019100522583970400_CIT0089","doi-asserted-by":"crossref","first-page":"S114","DOI":"10.1016\/S0163-4453(17)30201-3","article-title":"Pertussis disease and transmission and host responses: insights from the baboon model of pertussis","volume":"74","author":"Pinto","year":"2017","journal-title":"J Infect"},{"key":"2019100522583970400_CIT0090","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1542\/peds.2011-2594","article-title":"Why do pertussis vaccines fail?","volume":"129","author":"Cherry","year":"2012","journal-title":"Pediatrics"},{"key":"2019100522583970400_CIT0091","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1542\/peds.2014-4118","article-title":"Epidemic pertussis and acellular pertussis vaccine failure in the 21st century","volume":"135","author":"Cherry","year":"2015","journal-title":"Pediatrics"},{"key":"2019100522583970400_CIT0092","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1128\/IAI.61.2.399-410.1993","article-title":"Cell-mediated immunity to Bordetella pertussis: role of Th1 cells in bacterial clearance in a murine respiratory infection model","volume":"61","author":"Mills","year":"1993","journal-title":"Infect Immun"},{"key":"2019100522583970400_CIT0093","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1016\/S0264-410X(98)00226-6","article-title":"A search for serologic correlates of immunity to Bordetella pertussis cough illnesses","volume":"16","author":"Cherry","year":"1998","journal-title":"Vaccine"},{"key":"2019100522583970400_CIT0094","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/S0264-410X(98)00227-8","article-title":"Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis","volume":"16","author":"Storsaeter","year":"1998","journal-title":"Vaccine"},{"key":"2019100522583970400_CIT0095","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1086\/381204","article-title":"Determination of serum antibody to Bordetella pertussis adenylate cyclase toxin in vaccinated and unvaccinated children and in children and adults with pertussis","volume":"38","author":"Cherry","year":"2004","journal-title":"Clin Infect Dis"},{"key":"2019100522583970400_CIT0096","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1128\/CVI.00469-09","article-title":"Antibody response patterns to Bordetella pertussis antigens in vaccinated (primed) and unvaccinated (unprimed) young children with pertussis","volume":"17","author":"Cherry","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"2019100522583970400_CIT0097","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1001\/jama.2012.6364","article-title":"Number and order of whole cell pertussis vaccines in infancy and disease protection","volume":"308","author":"Sheridan","year":"2012","journal-title":"JAMA"},{"key":"2019100522583970400_CIT0098","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1093\/infdis\/jiu322","article-title":"Estimating the effectiveness of tetanus-diphtheria-acellular pertussis vaccine (Tdap) for preventing pertussis: evidence of rapidly waning immunity and difference in effectiveness by Tdap brand","volume":"210","author":"Koepke","year":"2014","journal-title":"J Infect Dis"},{"key":"2019100522583970400_CIT0099","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1542\/peds.2014-3358","article-title":"Tdap vaccine effectiveness in adolescents during the 2012 Washington State pertussis epidemic","volume":"135","author":"Acosta","year":"2015","journal-title":"Pediatrics"},{"key":"2019100522583970400_CIT0100","doi-asserted-by":"crossref","first-page":"e20153326","DOI":"10.1542\/peds.2015-3326","article-title":"Waning Tdap effectiveness in adolescents","volume":"137","author":"Klein","year":"2016","journal-title":"Pediatrics"},{"key":"2019100522583970400_CIT0101","doi-asserted-by":"crossref","first-page":"S96","DOI":"10.1016\/j.cmi.2016.05.029","article-title":"Live pertussis vaccines: will they protect against carriage and spread of pertussis?","volume":"22","author":"Locht","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"2019100522583970400_CIT0102","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/infdis\/jix254","article-title":"Live attenuated pertussis vaccine BPZE1 protects baboons against Bordetella pertussis disease and infection","volume":"216","author":"Locht","year":"2017","journal-title":"J Infect Dis"},{"key":"2019100522583970400_CIT0103","doi-asserted-by":"crossref","first-page":"e65","DOI":"10.1371\/journal.ppat.0020065","article-title":"Live attenuated B pertussis as a single-dose nasal vaccine against whooping cough","volume":"2","author":"Mielcarek","year":"2006","journal-title":"PLoS Pathog"},{"key":"2019100522583970400_CIT0104","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1586\/14760584.2014.942222","article-title":"Live attenuated vaccines against pertussis","volume":"13","author":"Locht","year":"2014","journal-title":"Expert Rev Vaccines"},{"key":"2019100522583970400_CIT0105","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1542\/peds.68.5.650","article-title":"Nature and rates of adverse reactions associated with DTP and DT immunizations in infants and children","volume":"68","author":"Cody","year":"1981","journal-title":"Pediatrics"},{"key":"2019100522583970400_CIT0106","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1097\/00006454-198908000-00006","article-title":"Analyses of adverse reactions to diphtheria and tetanus toxoids and pertussis vaccine by vaccine lot, endotoxin content, pertussis vaccine potency and percentage of mouse weight gain","volume":"8","author":"Baraff","year":"1989","journal-title":"Pediatr Infect Dis J"},{"key":"2019100522583970400_CIT0107","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1128\/AAC.6.4.422","article-title":"Inactivation of endotoxin by polymyxin B","volume":"6","author":"Cooperstock","year":"1974","journal-title":"Antimicrob Agents Chemother"},{"key":"2019100522583970400_CIT0108","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1017\/S0022172400069618","article-title":"Reducing the endotoxic activity of pertussis vaccine","volume":"87","author":"Bannatyne","year":"1981","journal-title":"J Hyg (Lond)"},{"key":"2019100522583970400_CIT0109","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0264-410X(86)90043-5","article-title":"Cleaning up pertussis vaccine","volume":"4","author":"Bannatyne","year":"1986","journal-title":"Vaccine"},{"key":"2019100522583970400_CIT0110","doi-asserted-by":"crossref","first-page":"339","DOI":"10.4161\/hv.22847","article-title":"An improved whole cell pertussis vaccine with reduced content of endotoxin","volume":"9","author":"Dias","year":"2013","journal-title":"Hum Vaccin Immunother"},{"key":"2019100522583970400_CIT0111","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1128\/CVI.00339-08","article-title":"Immunogenicity of a whole-cell pertussis vaccine with low lipopolysaccharide content in infants","volume":"16","author":"Zorzeto","year":"2009","journal-title":"Clin Vaccine Immunol"},{"key":"2019100522583970400_CIT0112","first-page":"1159","article-title":"Pertussis and other Bordetella infections","volume-title":"Feigin and Cherry\u2019s Textbook of Pediatric Infectious Disease","author":"Cherry","year":"2019","edition":"8th ed"},{"key":"2019100522583970400_CIT0113","doi-asserted-by":"crossref","first-page":"4281","DOI":"10.1128\/JB.01875-07","article-title":"Glucosamine found as a substituent of both phosphate groups in Bordetella lipid A backbone: role of a BvgAS-activated ArnT ortholog","volume":"190","author":"Nico","year":"2008","journal-title":"J Bacteriol"},{"key":"2019100522583970400_CIT0114","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1086\/657409","article-title":"Variability in the lipooligosaccharide structure and endotoxicity among Bordetella pertussis strains","volume":"202","author":"Marr","year":"2010","journal-title":"J Infect Dis"},{"key":"2019100522583970400_CIT0115","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1128\/IAI.01346-09","article-title":"Substitution of the Bordetella pertussis lipid A phosphate groups with glucosamine is required for robust NF-kappaB activation and release of proinflammatory cytokines in cells expressing human but not murine Toll-like receptor 4-MD-2-CD14","volume":"78","author":"Marr","year":"2010","journal-title":"Infect Immun"},{"key":"2019100522583970400_CIT0116","doi-asserted-by":"crossref","first-page":"11751","DOI":"10.1074\/jbc.M112.434365","article-title":"Minor modifications to the phosphate groups and the C3\u2019 acyl chain length of lipid A in two Bordetella pertussis strains, BP338 and 18-323, independently affect Toll-like receptor 4 protein activation","volume":"288","author":"Shah","year":"2013","journal-title":"J Biol Chem"},{"key":"2019100522583970400_CIT0117","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3389\/fcimb.2013.00003","article-title":"Recognition of lipid A variants by the TLR4-MD-2 receptor complex","volume":"3","author":"Maeshima","year":"2013","journal-title":"Front Cell Infect Microbiol"},{"key":"2019100522583970400_CIT0118","doi-asserted-by":"crossref","first-page":"13440","DOI":"10.1074\/jbc.M115.653881","article-title":"Bordetella pertussis lipid A recognition by Toll-like receptor 4 and MD-2 is dependent on distinct charged and uncharged interfaces","volume":"290","author":"Maeshima","year":"2015","journal-title":"J Biol Chem"}],"container-title":["Journal of the Pediatric Infectious Diseases Society"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jpids\/article-pdf\/8\/4\/334\/30106988\/piz005.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jpids\/article-pdf\/8\/4\/334\/30106988\/piz005.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T03:36:54Z","timestamp":1694576214000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jpids\/article\/8\/4\/334\/5359449"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,22]]},"references-count":118,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2019,2,22]]},"published-print":{"date-parts":[[2019,9,25]]}},"URL":"https:\/\/doi.org\/10.1093\/jpids\/piz005","relation":{},"ISSN":["2048-7193","2048-7207"],"issn-type":[{"value":"2048-7193","type":"print"},{"value":"2048-7207","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,9]]},"published":{"date-parts":[[2019,2,22]]}}}